Overview

Established in 1995, Alpharetta, Georgia-based Proxima Therapeutics, Inc. is a privately held medical device company that develops and markets innovative radiation delivery systems for the treatment of solid cancerous tumors, with an initial focus on brain and breast cancer. Proxima's systems address an unmet clinical need for brain and breast radiation therapy by allowing physicians to deliver a higher and more targeted dose of radiation. This approach reduces treatment time, minimizes exposure to healthy tissue and reduces the potential for unwanted side effects. Proxima's proprietary, single-use devices position radiation directly within the post-surgical cavity, delivering radiation to the tissue that is at the highest risk for recurrence while minimizing damage to healthy tissue.